No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study

Aims. A new perspective on autoantibodies as pivotal players in the pathogenesis of type 1 diabetes (T1D) has recently emerged. Our key objective was to examine whether increased levels of autoantibodies against the β-cell autoantigens glutamic acid decarboxylase (isoform 65) (GADA) and insulinoma a...

Full description

Saved in:
Bibliographic Details
Main Authors: Steffen U. Thorsen, Christian B. Pipper, Henrik B. Mortensen, Flemming Pociot, Jesper Johannesen, Jannet Svensson
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/8350158
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554127596453888
author Steffen U. Thorsen
Christian B. Pipper
Henrik B. Mortensen
Flemming Pociot
Jesper Johannesen
Jannet Svensson
author_facet Steffen U. Thorsen
Christian B. Pipper
Henrik B. Mortensen
Flemming Pociot
Jesper Johannesen
Jannet Svensson
author_sort Steffen U. Thorsen
collection DOAJ
description Aims. A new perspective on autoantibodies as pivotal players in the pathogenesis of type 1 diabetes (T1D) has recently emerged. Our key objective was to examine whether increased levels of autoantibodies against the β-cell autoantigens glutamic acid decarboxylase (isoform 65) (GADA) and insulinoma associated antigen-2A (IA-2A) mirrored the 3.4% annual increase in incidence of T1D. Methods. From the Danish Childhood Diabetes Register, we randomly selected 500 patients and 500 siblings for GADA and IA-2A analysis (1997 through 2005). Blood samples were taken within three months after onset. A robust log-normal regression model was used. Nine hundred children and adolescents had complete records and were included in the analysis. Cochran-Armitage test for trend was used to evaluate changes in prevalence of autoantibody positivity by period. Results. No significant changes in levels of GADA and IA-2A were found over our 9-year study period. No trends in autoantibody positivity—in either patients or siblings—were found. Levels of GADA and IA-2A were significantly associated with HLA risk groups and GADA with age. Conclusion. The prevalence of positivity and the levels of GADA and IA-2A have not changed between 1997 and 2005 in newly diagnosed patients with T1D and their siblings without T1D.
format Article
id doaj-art-008c2fb6f4a840b68ab0bb54754dacc4
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-008c2fb6f4a840b68ab0bb54754dacc42025-02-03T05:52:13ZengWileyInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/83501588350158No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish StudySteffen U. Thorsen0Christian B. Pipper1Henrik B. Mortensen2Flemming Pociot3Jesper Johannesen4Jannet Svensson5Copenhagen Diabetes Research Center (CPH-DIRECT), Department of Paediatrics, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, DenmarkDepartment of Public Health, Section of Biostatistics, University of Copenhagen, Øster Farimagsgade 5, 1710 Copenhagen K, DenmarkCopenhagen Diabetes Research Center (CPH-DIRECT), Department of Paediatrics, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, DenmarkCopenhagen Diabetes Research Center (CPH-DIRECT), Department of Paediatrics, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, DenmarkCopenhagen Diabetes Research Center (CPH-DIRECT), Department of Paediatrics, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, DenmarkCopenhagen Diabetes Research Center (CPH-DIRECT), Department of Paediatrics, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, DenmarkAims. A new perspective on autoantibodies as pivotal players in the pathogenesis of type 1 diabetes (T1D) has recently emerged. Our key objective was to examine whether increased levels of autoantibodies against the β-cell autoantigens glutamic acid decarboxylase (isoform 65) (GADA) and insulinoma associated antigen-2A (IA-2A) mirrored the 3.4% annual increase in incidence of T1D. Methods. From the Danish Childhood Diabetes Register, we randomly selected 500 patients and 500 siblings for GADA and IA-2A analysis (1997 through 2005). Blood samples were taken within three months after onset. A robust log-normal regression model was used. Nine hundred children and adolescents had complete records and were included in the analysis. Cochran-Armitage test for trend was used to evaluate changes in prevalence of autoantibody positivity by period. Results. No significant changes in levels of GADA and IA-2A were found over our 9-year study period. No trends in autoantibody positivity—in either patients or siblings—were found. Levels of GADA and IA-2A were significantly associated with HLA risk groups and GADA with age. Conclusion. The prevalence of positivity and the levels of GADA and IA-2A have not changed between 1997 and 2005 in newly diagnosed patients with T1D and their siblings without T1D.http://dx.doi.org/10.1155/2016/8350158
spellingShingle Steffen U. Thorsen
Christian B. Pipper
Henrik B. Mortensen
Flemming Pociot
Jesper Johannesen
Jannet Svensson
No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
International Journal of Endocrinology
title No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
title_full No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
title_fullStr No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
title_full_unstemmed No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
title_short No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
title_sort no contribution of gad 65 and ia 2 autoantibodies around time of diagnosis to the increasing incidence of juvenile type 1 diabetes a 9 year nationwide danish study
url http://dx.doi.org/10.1155/2016/8350158
work_keys_str_mv AT steffenuthorsen nocontributionofgad65andia2autoantibodiesaroundtimeofdiagnosistotheincreasingincidenceofjuveniletype1diabetesa9yearnationwidedanishstudy
AT christianbpipper nocontributionofgad65andia2autoantibodiesaroundtimeofdiagnosistotheincreasingincidenceofjuveniletype1diabetesa9yearnationwidedanishstudy
AT henrikbmortensen nocontributionofgad65andia2autoantibodiesaroundtimeofdiagnosistotheincreasingincidenceofjuveniletype1diabetesa9yearnationwidedanishstudy
AT flemmingpociot nocontributionofgad65andia2autoantibodiesaroundtimeofdiagnosistotheincreasingincidenceofjuveniletype1diabetesa9yearnationwidedanishstudy
AT jesperjohannesen nocontributionofgad65andia2autoantibodiesaroundtimeofdiagnosistotheincreasingincidenceofjuveniletype1diabetesa9yearnationwidedanishstudy
AT jannetsvensson nocontributionofgad65andia2autoantibodiesaroundtimeofdiagnosistotheincreasingincidenceofjuveniletype1diabetesa9yearnationwidedanishstudy